M. Galanski

发表

Influence of reducing agents on the cytotoxic activity of platinum(IV) complexes: induction of G2/M arrest, apoptosis and oxidative stress in A2780 and cisplatin resistant A2780cis cell lines.

V. Pichler, Simone Göschl, Ekaterina Schreiber-Brynzak, 2015, Metallomics : integrated biometal science.

Biological activity of PtIV prodrugs triggered by riboflavin-mediated bioorthogonal photocatalysis

W. Berger, M. Galanski, B. Keppler, 2018, Scientific Reports.

Ionic liquids for extraction of metals and metal containing compounds from communal and industrial waste water.

M. Galanski, B. Keppler, G. Koellensperger, 2011, Water research.

Carboxylation of Dihydroxoplatinum(IV) Complexes via a New Synthetic Pathway.

M. Galanski, B. Keppler, 1996, Inorganic chemistry.

Synthesis, characterization, lipophilicity and cytotoxic properties of novel bis(carboxylato)oxalatobis(1-propylamine)platinum(IV) complexes

M. Jakupec, M. Galanski, B. Keppler, 2019, Inorganica Chimica Acta.

Impact of the equatorial coordination sphere on the rate of reduction, lipophilicity and cytotoxic activity of platinum(IV) complexes.

M. Jakupec, M. Galanski, B. Keppler, 2017, Journal of inorganic biochemistry.

Tetracarboxylatoplatinum(IV) complexes featuring monodentate leaving groups - A rational approach toward exploiting the platinum(IV) prodrug strategy.

M. Jakupec, M. Galanski, B. Keppler, 2015, Journal of inorganic biochemistry.

A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugs.

W. Berger, F. Jensen, Simone Göschl, 2014, Journal of medicinal chemistry.

Unsymmetric mono- and dinuclear platinum(IV) complexes featuring an ethylene glycol moiety: synthesis, characterization, and biological activity.

W. Berger, V. Pichler, M. Jakupec, 2012, Journal of medicinal chemistry.

Novel tetracarboxylatoplatinum(IV) complexes as carboplatin prodrugs.

M. Jakupec, M. Galanski, B. Keppler, 2012, Dalton transactions.

Design, synthesis, physical and chemical characterisation, and biological interactions of lectin-targeted latex nanoparticles bearing Gd–DTPA chelates: an exploration of magnetic resonance molecular imaging (MRMI)

W. Buchberger, C. Kremser, M. Galanski, 2005, Histochemistry and Cell Biology.

Enhancing lipophilicity as a strategy to overcome resistance against platinum complexes?

U. Jaehde, M. Galanski, B. Keppler, 2011, Journal of inorganic biochemistry.

Water‐Soluble Cationic Derivatives of Indirubin, the Active Anticancer Component from Indigo naturalis

W. Berger, M. Jakupec, M. Galanski, 2012, Chemistry & biodiversity.

A SAR study of novel antiproliferative ruthenium and osmium complexes with quinoxalinone ligands in human cancer cell lines.

W. Berger, M. Jakupec, M. Galanski, 2012, Journal of medicinal chemistry.

Comparison of the binding behavior of oxaliplatin, cisplatin and analogues to 5'-GMP in the presence of sulfur-containing molecules by means of capillary electrophoresis and electrospray mass spectrometry.

M. Galanski, B. Keppler, A. Küng, 2001, Journal of inorganic biochemistry.

Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches.

M. Jakupec, M. Galanski, B. Keppler, 2005, Current medicinal chemistry.

Nano-scale imaging of dual stable isotope labeled oxaliplatin in human colon cancer cells reveals the nucleolus as a putative node for therapeutic effect

A. Schintlmeister, M. Jakupec, M. Galanski, 2020, Nanoscale advances.

Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs

W. Berger, M. Jakupec, M. Galanski, 2012, Molecular Pharmacology.

Synthesis, Characterization, and Time‐Dependent NMR Spectroscopy Studies of (SP‐4‐2)‐[(trans‐1R,2R/1S,2S‐15N2)‐Cyclohexane‐1,2‐diamine][(13C2)oxalato]platinum(II)

M. Galanski, B. Keppler, D. Höfer, 2017 .

Low generation PAMAM dendrimers as drug carriers for Pt(IV) complexes

Ekaterina Schreiber-Brynzak, M. Jakupec, M. Galanski, 2016 .

Multi-scale imaging of anticancer platinum(iv) compounds in murine tumor and kidney

A. Schintlmeister, W. Berger, M. Jakupec, 2016, Chemical science.

The influence of calcium ions on the DNA binding behaviour of a new platinum(II) compound linked to an amino phosphonic acid

M. Galanski, B. Keppler, E. Vogel, 1997 .

Tetrachloroferrate containing ionic liquids: Magnetic- and aggregation behavior

T. Hofmann, M. Galanski, B. Keppler, 2010 .

Analysis of quaternary ammonium and phosphonium ionic liquids by reversed-phase high-performance liquid chromatography with charged aerosol detection and unified calibration.

M. Galanski, B. Keppler, W. Lindner, 2008, Journal of chromatography. A.

Tuning of lipophilicity and cytotoxic potency by structural variation of anticancer platinum(IV) complexes.

M. Jakupec, M. Galanski, B. Keppler, 2011, Journal of inorganic biochemistry.

Impact of metal coordination on cytotoxicity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and novel insights into terminal dimethylation.

W. Berger, M. Jakupec, M. Galanski, 2009, Journal of medicinal chemistry.

Inductively coupled plasma mass spectrometry for metallodrug development: albumin binding and serum distribution of cytotoxic cis- and trans-isomeric platinum(II) complexes.

A. Timerbaev, M. Bolshov, M. Galanski, 2014, Journal of inorganic biochemistry.

Synthesis, structure, spectroscopic and in vitro antitumour studies of a novel gallium(III) complex with 2-acetylpyridine (4)N-dimethylthiosemicarbazone.

M. Jakupec, M. Galanski, B. Keppler, 2002, Journal of inorganic biochemistry.

Influence of the Number of Axial Bexarotene Ligands on the Cytotoxicity of Pt(IV) Analogs of Oxaliplatin

M. Galanski, B. Keppler, A. Lobas, 2017, Bioinorganic chemistry and applications.

Lectin–Gd-Loaded Chitosan Hydrogel Nanoparticles: A New Biospecific Contrast Agent for MRI

C. Kremser, M. Galanski, B. Keppler, 2011, Molecular Imaging and Biology.

Lectin Conjugates as Biospecific Contrast Agents for MRI. Coupling of Lycopersicon esculentum Agglutinin to Linear Water-Soluble DTPA-Loaded Oligomers

C. Kremser, M. Galanski, B. Keppler, 2011, Molecular Imaging and Biology.

Theoretical Investigations and Density Functional Theory Based Quantitative Structure–Activity Relationships Model for Novel Cytotoxic Platinum(IV) Complexes

Frank Jensen, Bernhard K. Keppler, F. Jensen, 2012, Journal of medicinal chemistry.

Turbulent flow chromatography in combination with HPLC-ICP-MS for high-throughput analysis of free, intact metal based drugs in biomedical samples

M. Galanski, B. Keppler, G. Koellensperger, 2016 .

The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs.

Simone Göschl, M. Jakupec, M. Galanski, 2016, Journal of inorganic biochemistry.

Platinum(IV) Complexes Featuring Axial (1, 4–13C2)Succinato Ligands – Synthesis, Characterization, and Preliminary Investigations in Cancer Cell Lysates

M. Galanski, B. Keppler, Jelena Banfić, 2013 .

Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin

M. Jakupec, M. Galanski, B. Keppler, 2011, European journal of medicinal chemistry.

Novel bis(carboxylato)dichlorido(ethane-1,2-diamine)platinum(IV) complexes with exceptionally high cytotoxicity.

M. Jakupec, M. Galanski, B. Keppler, 2008, Journal of inorganic biochemistry.

Novel di- and tetracarboxylatoplatinum(IV) complexes. Synthesis, characterization, cytotoxic activity, and DNA platination.

M. Jakupec, M. Galanski, B. Keppler, 2007, Journal of medicinal chemistry.

An Entry to Novel Platinum Complexes: Carboxylation of Dihydroxoplatinum(IV) Complexes with Succinic Anhydride and Subsequent Derivatization

M. Galanski, B. Keppler, Michael R. Reithofer, 2006 .

Recent developments in the field of anticancer platinum complexes.

M. Galanski, 2006, Recent patents on anti-cancer drug discovery.

Tumor microenvironment in focus: LA-ICP-MS bioimaging of a preclinical tumor model upon treatment with platinum(IV)-based anticancer agents.

W. Berger, M. Galanski, B. Keppler, 2015, Metallomics : integrated biometal science.

Effect of metal ion complexation and chalcogen donor identity on the antiproliferative activity of 2-acetylpyridine N,N-dimethyl(chalcogen)semicarbazones.

M. Jakupec, M. Galanski, B. Keppler, 2007, Journal of inorganic biochemistry.

Novel Endothall‐Containing Platinum(IV) Complexes: Synthesis, Characterization, and Cytotoxic Activity

M. Jakupec, M. Galanski, B. Keppler, 2008, Chemistry & biodiversity.

Solid-phase synthesis of oxaliplatin-TAT peptide bioconjugates.

M. Jakupec, M. Galanski, B. Keppler, 2012, Dalton transactions.

Is reduction required for antitumour activity of platinum(IV) compounds? Characterisation of a platinum(IV)–nucleotide adduct [enPt(OCOCH3)3(5′-GMP)] by NMR spectroscopy and ESI-MS

M. Galanski, B. Keppler, 2000 .

A fluorescent oxaliplatin derivative for investigation of oxaliplatin resistance using imaging techniques

M. Galanski, Sabrina Gollos, G. Kalayda, 2017, JBIC Journal of Biological Inorganic Chemistry.

Keggin-type polyoxotungstates as mushroom tyrosinase inhibitors - A speciation study

M. Galanski, B. Boesen, A. Rompel, 2019, Scientific Reports.

Tumor‐Targeting Strategies with Anticancer Platinum Complexes

M. Galanski, B. Keppler, 2011 .

Synthesis, crystal structure and cytotoxicity of new oxaliplatin analogues indicating that improvement of anticancer activity is still possible.

M. Jakupec, M. Galanski, B. Keppler, 2004, European journal of medicinal chemistry.

1,1,3,3-Tetramethyl-1,3-disila-2-oxa[3]ferrocenophane: improved synthesis and new crystal structure

M. Galanski, B. Keppler, G. Giester, 2002 .

Greener synthesis of new ammonium ionic liquids and their potential as extracting agents

M. Galanski, B. Keppler, M. Groessl, 2008 .

Recent developments in the field of tumor-inhibiting metal complexes.

M. Jakupec, M. Galanski, B. Keppler, 2003, Current pharmaceutical design.

The relation between stereochemistry and biological activity of platinum(II) complexes chelated with chiral diamine ligands: an intricate problem.

M. Galanski, F. Dufrasne, 2007, Current pharmaceutical design.

Species specific IDMS for accurate quantification of carboplatin in urine by LC-ESI-TOFMS and LC-ICP-QMS

G. Stingeder, M. Galanski, B. Keppler, 2007 .

Vanadium(V) Complexes with Substituted 1,5-bis(2-hydroxybenzaldehyde)carbohydrazones and Their Use As Catalyst Precursors in Oxidation of Cyclohexane.

M. Galanski, L. Martins, A. Pombeiro, 2016, Inorganic chemistry.

Antitumour metal compounds: more than theme and variations.

M. Jakupec, M. Galanski, B. Keppler, 2008, Dalton transactions.

Phosphonium and Ammonium Ionic Liquids with Aromatic Anions: Synthesis, Properties, and Platinum Extraction

M. Galanski, B. Keppler, M. Groessl, 2010 .

The first ruthenium-based paullones: syntheses, X-ray diffraction structures, and spectroscopic and antiproliferative properties in vitro.

M. Jakupec, M. Galanski, B. Keppler, 2007, Inorganic chemistry.

Novel oximato-bridged platinum(II) di- and trimer(s): synthetic, structural, and in vitro anticancer activity studies.

M. Jakupec, M. Galanski, B. Keppler, 2012, Inorganic chemistry.

(Aminoethanol)dichloroplatinum(II) complexes: influence of the hydroxyethyl moiety on 5'-GMP and DNA binding, intramolecular stability, the partition coefficient and anticancer activity.

W. Zimmermann, M. Galanski, J. Reedijk, 2002, Journal of inorganic biochemistry.

Enhancing the cytotoxic activity of anticancer Pt(IV) complexes by introduction of lonidamine as an axial ligand

A. Timerbaev, M. Galanski, B. Keppler, 2017 .

Tumor‐inhibiting platinum(II) complexes with aminoalcohol ligands: Comparison of the mode of action by capillary electrophoresis and electrospray ionization‐mass spectrometry

A. Timerbaev, M. Galanski, B. Keppler, 2003, Electrophoresis.

An electrochemical study of antineoplastic gallium, iron and ruthenium complexes with redox noninnocent alpha-N-heterocyclic chalcogensemicarbazones.

M. Galanski, B. Keppler, E. Reisner, 2008, Inorganic chemistry.

Novel and Mild Route to Phthalocyanines and 3-Iminoisoindolin-1-ones via N,N-Diethylhydroxylamine-Promoted Conversion of Phthalonitriles and a Dramatic Solvent-Dependence of the Reaction

M. Galanski, A. Pombeiro, M. N. Kopylovich, 2008 .

Tumour-inhibiting platinum complexes--state of the art and future perspectives.

M. Jakupec, M. Galanski, B. Keppler, 2003, Reviews of physiology, biochemistry and pharmacology.

Metal-based paullones as putative CDK inhibitors for antitumor chemotherapy.

W. Berger, M. Jakupec, M. Galanski, 2007, Journal of medicinal chemistry.

In vitro anticancer activity and biologically relevant metabolization of organometallic ruthenium complexes with carbohydrate-based ligands.

Michael Groessl, Christian G Hartinger, Paul J Dyson, 2008, Chemistry.

Redox behavior of tumor-inhibiting ruthenium(III) complexes and effects of physiological reductants on their binding to GMP.

M. Jakupec, M. Galanski, B. Keppler, 2006, Dalton transactions.

Iminoacylation. 3. Formation of platinum(IV)-based metallaligands due to facile one-end addition of vic-dioximes to coordinated organonitriles.

M. Galanski, A. Pombeiro, G. Wagner, 2000, Inorganic chemistry.

Cellular accumulation and DNA interaction studies of cytotoxic trans-platinum anticancer compounds

M. Jakupec, M. Galanski, B. Keppler, 2012, JBIC Journal of Biological Inorganic Chemistry.

{(1R,2R,4R)-4-methyl-1,2-cyclohexanediamine}oxalatoplatinum(II): a novel enantiomerically pure oxaliplatin derivative showing improved anticancer activity in vivo.

W. Berger, M. Jakupec, M. Galanski, 2010, Journal of medicinal chemistry.

Novel cis- and trans-configured bis(oxime)platinum(II) complexes: synthesis, characterization, and cytotoxic activity.

M. Jakupec, M. Galanski, B. Keppler, 2010, Inorganic chemistry.

New C2-Chiral 1,1′-Bis(Oxazoline-2-YL)-Ferrocenes – Synthesis and Crystal Structure

M. Galanski, G. Giester, C. Hartinger, 2001 .

Analysis of Platinum Adducts with DNA Nucleotides and Nucleosides by Capillary Electrophoresis Coupled to ESI‐MS: Indications of Guanosine 5′‐Monophosphate O6–N7 Chelation

U. Jaehde, M. Galanski, B. Keppler, 2004, Chembiochem : a European journal of chemical biology.

Redox-active antineoplastic ruthenium complexes with indazole: correlation of in vitro potency and reduction potential.

M. Jakupec, M. Galanski, B. Keppler, 2005, Journal of medicinal chemistry.

Antiproliferative Copper(II) and Platinum(II) Complexes with Bidentate N,N‐Donor Ligands

M. Jakupec, M. Galanski, B. Keppler, 2017 .

Unprecedented twofold intramolecular hydroamination in diam(m)ine-dicarboxylatodichloridoplatinum(IV) complexes - ethane-1,2-diamine vs. ammine ligands.

M. Galanski, B. Keppler, V. Arion, 2008, Chemical communications.

Diamminetetrakis(carboxylato)platinum(IV) Complexes – Synthesis, Characterization, and Cytotoxicity

M. Jakupec, M. Galanski, B. Keppler, 2012, Chemistry & biodiversity.

Methyl-substituted trans-1,2-cyclohexanediamines as new ligands for oxaliplatin-type complexes

M. Galanski, B. Keppler, W. Lindner, 2008 .

Synthesis and structure-activity relationships of mono- and dialkyl-substituted oxaliplatin derivatives.

M. Galanski, B. Keppler, Nikolai Graf von Keyserlingk, 2005, European journal of medicinal chemistry.

Crystal structure of trans-dichloro(dimethylsulfoxide)(diphenylsulimide)-platinum (II)toluene hemisolvate ,Ptcl2(C2H6SO)(C2H6SNH) ·C12H10SNH · ½C7H8

M. Galanski, M. Haukka, V. Kukushkin, 2006 .

Crystal structure of trans-dichloro(dimethylsulfoxide)(diphenylsulfimide)- platinum(II) toluene hemisolvate, PtCl2(C2H6SO)(C12H10SNH) · ½C7H8

M. Galanski, B. Keppler, M. Haukka, 2006 .

First example of the solid-state thermal cyclometalation of ligated benzophenone imine giving novel luminescent platinum(II) species.

M. Galanski, B. Keppler, J. Schneider, 2007, Inorganic chemistry.

Regioselective addition of bifunctional oximehydroxamic acid by the hydroxamic group to Pt(IV)-coordinated nitriles

M. Galanski, A. Pombeiro, V. Kukushkin, 2008 .

Synthesis and crystal structure of N-phenyl-N′-(pyridin-2-ylmethyl)-S-methyl-thiouronium iodide

M. Galanski, B. Keppler, A. Stojanovic, 2010 .

1,1'‐Bis(oxazolin‐2‐yl)ferrocenes: An Investigation of Their Complexation Behavior toward [Pd(η3‐allyl)Cl]2

M. Galanski, B. Keppler, G. Giester, 2005 .

Synthesis and structures of novel 1-methylcytosinato-bridged (ethylenediamine)platinum(II) and platinum(III) dinuclear complexes.

M. Galanski, B. Keppler, V. Arion, 2010, Dalton transactions.

Resistance against novel anticancer metal compounds: differences and similarities.

W. Berger, M. Jakupec, M. Galanski, 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Comparative in vitro and in vivo pharmacological investigation of platinum(IV) complexes as novel anticancer drug candidates for oral application

W. Berger, M. Galanski, B. Keppler, 2014, JBIC Journal of Biological Inorganic Chemistry.

Platinum(IV) Complexes Featuring One or Two Axial Ferrocene Bearing Ligands – Synthesis, Characterization, and Cytotoxicity

M. Jakupec, M. Galanski, B. Keppler, 2014 .

Tumour-inhibiting platinum(II) complexes with aminoalcohol ligands: biologically important transformations studied by micellar electrokinetic chromatography, nuclear magnetic resonance spectroscopy and mass spectrometry.

A. Timerbaev, M. Galanski, B. Keppler, 2005, The Analyst.

Bulky N(,N)-(di)alkylethane-1,2-diamineplatinum(II) compounds as precursors for generating unsymmetrically substituted platinum(IV) complexes.

V. Pichler, Simone Göschl, M. Jakupec, 2013, Inorganic chemistry.

Synthesis, characterization, and cytotoxic activity of novel potentially pH-sensitive nonclassical platinum(II) complexes featuring 1,3-dihydroxyacetone oxime ligands.

M. Jakupec, M. Galanski, B. Keppler, 2011, Inorganic chemistry.

Bis(2-amino alcohol-κN)dicarboxylatoplatinum(II) Complexes – Elegant Synthesis via Ring-Opening of Bis(2-amino alcoholato-κ2N,O)platinum(II) Species with Dicarboxylic Acids

M. Galanski, B. Keppler, V. Arion, 2006 .

Glucose ferrocenyl-oxazolines : Coordination behavior toward [Pd(η3-allyl)Cl]2 studied by ESI-MS

M. Galanski, C. Hartinger, Michael R. Reithofer, 2005 .

The first metal-based paullone derivative with high antiproliferative activity in vitro.

M. Jakupec, M. Galanski, B. Keppler, 2006, Inorganic chemistry.

Synthesis and structural peculiarities of gallium Complexes with novel paullone derivatives

M. Galanski, B. Keppler, G. Giester, 2008 .

Carboxylation of dihydroxoplatinum(IV) complexes with acyl chlorides. Crystal structures of the trans-R,R- and trans-S,S-isomer of (OC-6-33)-bis(1-adamantanecarboxylato)-(cyclohexane-1,2-diamine)dichloroplatinum(IV)

M. Galanski, B. Keppler, 1997 .

Reaction monitoring of platinum(II) complex--5'-guanosine monophosphate adduct formation by ion exchange liquid chromatography/electrospray ionization mass spectrometry.

M. Galanski, B. Keppler, P. Zöllner, 2001, Journal of mass spectrometry : JMS.

Development and Validation of Liquid Chromatography-Based Methods to Assess the Lipophilicity of Cytotoxic Platinum(IV) Complexes

V. Pichler, M. Galanski, B. Keppler, 2018, Inorganics.

Platinum metallodrug‐protein binding studies by capillary electrophoresis‐inductively coupled plasma‐mass spectrometry: Characterization of interactions between Pt(II) complexes and human serum albumin

A. Timerbaev, O. Semenova, M. Galanski, 2004, Electrophoresis.

Determination of platinum in protein-bound CDDP and DBP by inductively coupled plasma optical emission spectrometry and electrothermal atomic absorption spectrometry

M. Galanski, B. Keppler, Thorsten J. Einhäuser, 1996 .

The first example of MEEKC‐ICP‐MS coupling and its application for the analysis of anticancer platinum complexes

M. Galanski, B. Keppler, M. Groessl, 2010, Electrophoresis.

Influence of ascorbic acid on the activity of the investigational anticancer drug KP1019

W. Berger, M. Jakupec, M. Galanski, 2011, JBIC Journal of Biological Inorganic Chemistry.

First Isolation of an Enol of a Carboxylic Acid by Complexation to an (Ethane‐1,2‐diamine)‐platinum(II) Fragment

M. Galanski, B. Keppler, B. Nuber, 1995 .

Prediction of logP for Pt(II) and Pt(IV) complexes: Comparison of statistical and quantum-chemistry based approaches.

Igor V Tetko, Mauro Ravera, James A Platts, 2016, Journal of inorganic biochemistry.

Behavior of platinum(iv) complexes in models of tumor hypoxia: cytotoxicity, compound distribution and accumulation

W. Berger, V. Pichler, Ekaterina Schreiber-Brynzak, 2016, Metallomics.

The impact of whole human blood on the kinetic inertness of platinum(iv) prodrugs – an HPLC-ICP-MS study

M. Galanski, B. Keppler, G. Koellensperger, 2018, Dalton transactions.

KINFix – A formalin-free non-commercial fixative optimized for histological, immunohistochemical and molecular analyses of neurosurgical tissue specimens

J. Hainfellner, M. Preusser, C. Hartmann, 2015, Clinical neuropathology.

Effect of reactivity on cellular accumulation and cytotoxicity of oxaliplatin analogues

U. Jaehde, M. Galanski, B. Keppler, 2012, JBIC Journal of Biological Inorganic Chemistry.

Synthesis, characterization, cytotoxic activity, and 19F NMR spectroscopic investigations of (OC-6-33)-diacetato(ethane-1,2-diamine)bis(3,3,3-trifluoropropanoato)platinum(IV) and its platinum(II) counterpart

M. Jakupec, M. Galanski, B. Keppler, 2019, Inorganica Chimica Acta.

Bis- and Tris(carboxylato)platinum(IV) Complexes with Mixed Am(m)ine Ligands in the trans Position Exhibiting Exceptionally High Cytotoxicity

M. Jakupec, M. Galanski, B. Keppler, 2015 .

Influence of extracellular pH on the cytotoxicity, cellular accumulation, and DNA interaction of novel pH-sensitive 2-aminoalcoholatoplatinum(II) complexes

W. Berger, M. Jakupec, M. Galanski, 2013, JBIC Journal of Biological Inorganic Chemistry.

Bis‐ and Tetrakis(carboxylato)platinum(IV) Complexes with Mixed Axial Ligands – Synthesis, Characterization, and Cytotoxicity

M. Jakupec, M. Galanski, B. Keppler, 2015, Chemistry & biodiversity.

Mono-carboxylated diaminedichloridoplatinum(IV) complexes--selective synthesis, characterization, and cytotoxicity.

V. Pichler, M. Jakupec, M. Galanski, 2011, Dalton transactions.

Searching for the magic bullet: anticancer platinum drugs which can be accumulated or activated in the tumor tissue.

M. Galanski, B. Keppler, 2007, Anti-cancer agents in medicinal chemistry.

Carboxylation of 2-Hydroxyethyl-Substituted Tetrachloro(ethane-1,2-diamine)platinum(IV) Complexes — A New Synthetic Approach to Anticancer Platinum Compounds

W. Zimmermann, M. Galanski, B. Keppler, 2002 .

[RuCl3ind3] and [RuCl2ind4]: Two New Ruthenium Complexes derived from the Tumor-inhibiting RuIII Compound HInd (OC-6-11)-[RuCl4ind2] (ind = indazole)

M. Galanski, B. Keppler, G. Giester, 2001 .

Platinum(IV) Complexes Featuring Axial Michael Acceptor Ligands – Synthesis, Characterization, and Cytotoxicity

M. Jakupec, M. Galanski, B. Keppler, 2017 .

Capillary electrophoretic study of cisplatin interaction with nucleoside monophosphates, di- and trinucleotides.

M. Galanski, B. Keppler, W. Lindner, 1999, Journal of chromatography. A.

LA-ICP-MS imaging in multicellular tumor spheroids - a novel tool in the preclinical development of metal-based anticancer drugs.

Ekaterina Schreiber-Brynzak, M. Jakupec, M. Galanski, 2016, Metallomics : integrated biometal science.

Aluminum-Substituted Keggin Germanotungstate [HAl(H2O)GeW11O39]4–: Synthesis, Characterization, and Antibacterial Activity

D. Verbanac, M. Galanski, A. Rompel, 2020, Inorganic chemistry.

Capillary electrophoretic study of carboplatin and analogues with nucleoside monophosphates, di- and trinucleotides.

M. Galanski, B. Keppler, A. Zenker, 2001, Journal of inorganic biochemistry.

Kinetics of binding properties of 5'-GMP with cisplatin under simulated physiological conditions by capillary electrophoresis.

M. Galanski, B. Keppler, W. Lindner, 2000, Journal of Chromatography B: Biomedical Sciences and Applications.

Reaction of (SP-4-2)-dichlorobis(2-hydroxyethylamine)platinum(II) with 5′-GMP under simulated physiological conditions, a CZE-ESI-MS study

M. Galanski, B. Keppler, C. Baumgartner, 2002 .

HPIC–UV–ICP–SFMS study of the interaction of cisplatin with guanosine monophosphate

G. Stingeder, M. Galanski, B. Keppler, 2001, Analytical and Bioanalytical Chemistry.

Capillary zone electrophoresis and capillary zone electrophoresis-electrospray ionization mass spectrometry studies on the behavior of anticancer cis- and trans-[dihalidobis(2-propanone oxime)platinum(II)] complexes in aqueous solutions.

M. Galanski, B. Keppler, S. Meier, 2012, Journal of chromatography. A.

Synthesis and Characterization of [(1R,2R)‐trans‐Diaminocyclohexane]platinum(II) Coordinated to Sulfur and Selenium Amino Acids

H. Görls, M. Galanski, B. Keppler, 2006 .

Synthesis, crystal structure and pH dependent cytotoxicity of (SP-4-2)-bis(2-aminoethanolato-κ2N, O)platinum(II): a representative of novel pH sensitive anticancer platinum complexes

M. Jakupec, M. Galanski, B. Keppler, 2004 .

Design of Platinum Complexes with High Affinity for Osteosarcoma and Bone Metastases — Structure-Activity Relationship

M. Galanski, B. Keppler, S. Metzger, 1999 .

The Mode of Action of Antitumor Platinum Compounds Linked to Amino Phosphonic Acids with Particular Activity Against Bone Malignancies and the Influence of Calcium Ions onto the DNA Binding Behavior

M. Galanski, B. Keppler, S. Slaby, 1999 .

Synthesis, characterization, and in vitro antitumor activity of osteotropic diam(m)ineplatinum(II) complexes bearing a N,N-bis(phosphonomethyl)glycine ligand.

M. Jakupec, M. Galanski, B. Keppler, 2003, Journal of medicinal chemistry.

Bis(2-aminobutanol)dichloroplatinum(II) Complexes and Their Singly and Doubly Ring-Closed Butanolato Species − Novel Prodrugs for Platinum-Based Antitumour Chemotherapy?

M. Galanski, B. Keppler, V. Arion, 2003 .

The Intramolecular Ligand-Exchange Reaction of (SP-4-2)-Dichlorobis(2-hydroxyethylamine)platinum(II) and (OC-6-22)-Tetrachlorobis(2-hydroxyethylamine)platinum(IV), a1H and15N,1H-HMQC NMR Study

W. Zimmermann, M. Galanski, B. Keppler, 2001 .

Synthesis and structures of ( SP -4-2)-diiodobis(2-hydroxyethylamine)platinum(II), ( SP -4-2)-dichlorobis(2-hydroxyethylamine)platinum(II) and ( OC -6-22)-bis(2-hydroxyethylamine)tetrachloroplatinum(IV) in the crystal

W. Zimmermann, M. Galanski, B. Keppler, 1999 .

Time-dependent interactions of platinum(II) complexes with 5′-GMP under simulated physiological conditions studied by capillary electrophoresis

M. Galanski, B. Keppler, W. Lindner, 2000, JBIC Journal of Biological Inorganic Chemistry.

Synthesis, crystal structures, and electrospray ionisation mass spectrometry investigations of ether- and thioether-substituted ferrocenes

M. Galanski, B. Keppler, V. Arion, 2003 .

Novel glucose-ferrocenyl derivatives: synthesis and properties

M. Jakupec, M. Galanski, B. Keppler, 2002 .

Ruthenium− and Osmium−Arene Complexes of 2-Substituted Indolo[3,2-c]quinolines: Synthesis, Structure, Spectroscopic Properties, and Antiproliferative Activity

M. Jakupec, M. Galanski, B. Keppler, 2010, Organometallics.

Synthesis and New Crystal Structure of 1,1,3,3-Tetramethyl-1,3-Disila-2-Oxa[3] Ferrocenophane

M. Galanski, B. Keppler, G. Giester, 2001 .

Multi-scale imaging of anticancer platinum(iv) compounds in murine tumor and kidney

A. Schintlmeister, M. Jakupec, M. Galanski, 2016, Chemical science.

Synthesis, characterisation and cytotoxicity of [(1,10-phenanthroline)(1R,2R,4R/1S,2S,4S)-4-methyl-1,2-cyclohexanediamine)platinum(II)]2+ (PHEN-4-MeDACH)

M. Galanski, B. Keppler, K. B. Garbutcheon-Singh, 2016 .

Can neutral analytes be concentrated by transient isotachophoresis in micellar electrokinetic chromatography and how much?

A. Timerbaev, M. Galanski, B. Keppler, 2014, Journal of chromatography. A.

DNA interactions of pH-sensitive, antitumor bis(aminoalcohol)dichloroplatinum(II) complexes.

M. Galanski, B. Keppler, C. Hartinger, 2006, Biochemistry.

Synthesis, Cytotoxicity, and Structure-Activity Relationships of New Oxaliplatin Derivatives

M. Jakupec, M. Galanski, B. Keppler, 2005, Chemical Monthly.